Department of Oncology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan
Department of Internal Medicine, Fukuoka Wajiro Hospital, Fukuoka, Japan
Department of Pharmacy, Hamanomachi Hospital, Fukuoka, Japan
Department of Pharmacy, Hamanomachi Hospital, Fukuoka, Japan
Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan
Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan
Department of Pharmacy, Fukuoka University Hospital, Fukuoka, Japan
Department of Practical Pharmaceutical Science, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan
Division of Medical Oncology, Hematology, and Infection Diseases, Fukuoka University Hospital, Fukuoka, Japan
Division of Medical Oncology, Hematology, and Infection Diseases, Fukuoka University Hospital, Fukuoka, Japan
Department of Pharmacy, Kurume University Hospital, Fukuoka, Japan
Division of Gastroenterology, Kurume University Department of Medicine, Fukuoka, Japan
Department of Pharmacy, National Kyushu Cancer Center, Fukuoka, Japan
Department of Gastrointestinal and Medical Oncology, National Kyushu Cancer Center, Fukuoka, Japan
Department of Pharmacy, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
Department of Pharmacy, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
Department of Pharmacy, Saga-Ken Medical Centre Koseikan, Saga, Japan
Department of Medical Oncology, Saga-Ken Medical Centre Koseikan, Saga, Japan
Department of Pharmacy, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
Department of Medicine and Comprehensive Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan
Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
Copyright © 2017 Tsuyoshi Shirakawa, Tomoko Hara, Kojiro Hata, Kojiro Hata, Kimitaka Suetsugu, Hideki Kakimoto, Kentaro Ogata, Yousuke Ikari, Hidenori Sasaki, Makoto Takahashi, Masaru Fukahori, Miyuki Uoi, Taito Esaki, Mikako Hiraike, Toshinobu Hayashi, Akira Tokunaga, Norio Ureshino, Tsuneo Kuwamura, Hitoshi Kusaba, Kenji Mitsugi, Eishi Baba et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Shirakawa, T. , Hara, T. , Hata, K. , Hata, K. , Suetsugu, K. , Kakimoto, H. , Ogata, K. , Ikari, Y. , Sasaki, H. , Takahashi, M. , Fukahori, M. , Uoi, M. , Esaki, T. , Hiraike, M. , Hayashi, T. , Tokunaga, A. , Ureshino, N. , Kuwamura, T. , Kusaba, H. , Mitsugi, K. and Baba, E. (2017) Analysis of a Questionnaire Survey regarding Current Conditions against Exposure to Anticancer Drugs and Reports of Cancer Chemotherapy at Outpatient Departments in Japan.
Pharmacology & Pharmacy,
8, 140-152. doi:
10.4236/pp.2017.85010.